Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

A Retrospective Multicenter Study to Evaluate the Efficacy of Rabbit Antithymocyte Globulin (rATG) Immunosuppressive Therapy As First-Line Treatment of Aplastic Anemia

Suporn Chuncharunee, MD, Raymond SM Wong, MD, Ponlapat Rojnuckarin, MD PhD, Cheng-Shyong Chang, MD, Kian Meng Chang, MD, Meng-Yao Lu, MD, Wen-Li Hwang, MD, Liang Piu Koh, MD, Tsai-Yun Chen, MD, Anskar YH Leung, MD, Lalita Norasetthada, MD, Shih-Chung Wang, MD, Ming-Chih Chang, MD, Kang-Hsi Wu, MD, Surapol Issaragrisil, MD

Blood (2015) 126 (23): 1217.

https://doi.org/10.1182/blood.V126.23.1217.1217

Published: 2015

Journal Articles

Use of Immunoglobulin Infusions in the Management of Bortezomib-Induced Peripheral Neuropathy in Multiple Myeloma.

Gerrard Teoh, MD, Daryl Tan, MD, William Hwang, MD, Liang Piu Koh, MD, Charles Chuah, MD, Heng Joo Ng, MD

Blood (2006) 108 (11): 5097.

https://doi.org/10.1182/blood.V108.11.5097.5097

Published: 2006

Journal Articles

Factors Influencing Responsiveness to Bortezomib in Patients with Multiple Myeloma Suggest a Possible Role for Host Immunocompetency.

Gerrard Teoh, MD, Daryl Tan, MD, William Hwang, MD, Liang Piu Koh, MD, Charles Chuah, MD, Heng Joo Ng, MD

Blood (2006) 108 (11): 5100.

https://doi.org/10.1182/blood.V108.11.5100.5100

Published: 2006

Journal Articles

High Response and Complete Remission Rates in Relapsed/Refractory Multiple Myeloma Treated with Bortezomib, Thalidomide, Dexamethasone and Zoledronic Acid (VTD-Z) Combination Therapy.

Gerrard Teoh, MD, Daryl Tan, MD, William Hwang, MD, Liang Piu Koh, MD, Charles Chuah, MD, Heng Joo Ng, MD

Blood (2005) 106 (11): 5127.

https://doi.org/10.1182/blood.V106.11.5127.5127

Published: 2005

Journal Articles

Outcome and Immune Reconstitution Following T Cell Depleted Nonmyeloablative Allogeneic Transplantation Using Matched Donors.

David A. Rizzieri, MD, Liang Piu Koh, MD, Gwynn D. Long, MD, Cristina Gasparetto, MD, Jerald Z. Gong, MD, Anand S. Lagoo, MD, Donna Niedzwiecki, PhD, Keith M. Sullivan, MD, John Chute, MD, Mitchell Horwitz, MD, Morris Ashley, PharmD, Nelson J. Chao, MD

Blood (2005) 106 (11): 2036.

https://doi.org/10.1182/blood.V106.11.2036.2036

Published: 2005

Journal Articles

Partially HLA Matched, Non-Myeloablative Allogeneic Transplantation.

David A. Rizzieri, MD, Liang Piu Koh, MD, Gwynn D. Long, MD, Cristina Gasparetto, MD, Keith M. Sullivan, MD, Mitchell Horwitz, MD, John Chute, MD, Jerald Z. Gong, MD, Anand S. Lagoo, MD, Donna Niedzwiecki, PhD, Cong Xiao Lu, MD, Dawn Marshall, BS, Jeanette M. Dowell, MS, Nelson J. Chao, MD

Blood (2005) 106 (11): 2896.

https://doi.org/10.1182/blood.V106.11.2896.2896

Published: 2005

Journal Articles

Low Dose Dexamethasone and Thalidomide with Higher Frequency Zoledronic Acid (dtZ) for Multiple Myeloma.

Gerrard Teoh, MD, William Hwang, MD, Liang Piu Koh, MD, Mickey Koh, MD, Daryl Tan, MD, Charles Gullo, PhD

Blood (2004) 104 (11): 4915.

https://doi.org/10.1182/blood.V104.11.4915.4915

Published: 2004

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

A Retrospective Multicenter Study to Evaluate the Efficacy of Rabbit Antithymocyte Globulin (rATG) Immunosuppressive Therapy As First-Line Treatment of Aplastic Anemia

Use of Immunoglobulin Infusions in the Management of Bortezomib-Induced Peripheral Neuropathy in Multiple Myeloma.

Factors Influencing Responsiveness to Bortezomib in Patients with Multiple Myeloma Suggest a Possible Role for Host Immunocompetency.

High Response and Complete Remission Rates in Relapsed/Refractory Multiple Myeloma Treated with Bortezomib, Thalidomide, Dexamethasone and Zoledronic Acid (VTD-Z) Combination Therapy.

Outcome and Immune Reconstitution Following T Cell Depleted Nonmyeloablative Allogeneic Transplantation Using Matched Donors.

Partially HLA Matched, Non-Myeloablative Allogeneic Transplantation.

Low Dose Dexamethasone and Thalidomide with Higher Frequency Zoledronic Acid (dtZ) for Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Update search

A Retrospective Multicenter Study to Evaluate the Efficacy of Rabbit Antithymocyte Globulin (rATG) Immunosuppressive Therapy As First-Line Treatment of Aplastic Anemia

Use of Immunoglobulin Infusions in the Management of Bortezomib-Induced Peripheral Neuropathy in Multiple Myeloma.

Factors Influencing Responsiveness to Bortezomib in Patients with Multiple Myeloma Suggest a Possible Role for Host Immunocompetency.

High Response and Complete Remission Rates in Relapsed/Refractory Multiple Myeloma Treated with Bortezomib, Thalidomide, Dexamethasone and Zoledronic Acid (VTD-Z) Combination Therapy.

Outcome and Immune Reconstitution Following T Cell Depleted Nonmyeloablative Allogeneic Transplantation Using Matched Donors.

Partially HLA Matched, Non-Myeloablative Allogeneic Transplantation.

Low Dose Dexamethasone and Thalidomide with Higher Frequency Zoledronic Acid (dtZ) for Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only